Trials / Completed
CompletedNCT02385240
Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 552 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare safety and efficacy of Perrigo's rosacea drug product compared to an FDA approved rosacea drug product in the treatment of facial erythema of rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brimonidine Topical Gel, 0.33 percent (Perrigo) | |
| DRUG | Brimonidine Topical Gel, 0.33 percent (Reference) | |
| DRUG | Placebo gel |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-03-11
- Last updated
- 2021-10-22
- Results posted
- 2020-12-14
Source: ClinicalTrials.gov record NCT02385240. Inclusion in this directory is not an endorsement.